CMS Report Highlights how DIR Reduces Beneficiary Premiums in Medicare Part D

WASHINGTON, Jan. 27, 2017 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) issued the following statement on the Centers for Medicare & Medicaid Services (CMS) report regarding direct and indirect remuneration (DIR) in Medicare Part D:

"CMS's report highlights how DIR reduces premiums for Medicare Part D beneficiaries, which leads to lower costs for the federal government. Stable and affordable premiums contribute to a 90% satisfaction rate among Part D enrollees for their drug plan. 

We look forward to working with the new Administration, congressional leaders and other stakeholders to ensure that the competitive Part D model remains affordable and successful in the years to come."

PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cms-report-highlights-how-dir-reduces-beneficiary-premiums-in-medicare-part-d-300398277.html

SOURCE Pharmaceutical Care Management Association